Resultados de la búsqueda 61-70 of 441 for Apple Cider Vinegar

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the incidence of immune checkpoint inhibitors (ICI)-induced colitis (IIC) in patients with solid malignancies receiving over-the-counter multi- ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Venetoclax may stop the growth of cancer cells by ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. Giving venetoclax with ibrutinib and rituximab with ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    To evaluate the safety of multi-strain probiotic blend in cancer patients receiving ICIs. To evaluate the clinical outcomes related to IIC, including the ...